NCT04565600View on ClinicalTrials.gov

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

April 22, 2021

Study Completion Date

June 28, 2021

Conditions
Pain Syndrome
Interventions
DRUG

Etoricoxib

Etoricoxib 60 Mg Oral Tablet

Trial Locations (1)

510080

Guangdong General Hospital, Guangzhou

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT04565600 - Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib | Biotech Hunter | Biotech Hunter